Sheba Medical Center: Multiple Sclerosis trials

The registry lists 11 Multiple Sclerosis studies with Sheba Medical Center as lead sponsor. 0 are open to participants now and 0 have results posted.

Phase 1 3Phase 2 2Phase 3 1Phase 4 1No phase 5(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Immune Response to COVID-19 Vaccine in Multiple Sclerosis Patients Treated With Teriflunomide and AlemtuzumabStatus unknownNCT05075499Not applicable
• Deciphering the Role of the Gut Microbiota in Multiple SclerosisStatus unknownNCT02580435
• Efficacy of Dalfampridine on Upper Extremity Function in Patients With MSStatus unknownNCT02259361Phase 4
• Correlation Between Cognitive Functions and MRI in Multiple SclerosisStatus unknownNCT00423111
• Measuring the Balance Improvement on Multiple Sclerosis Patients After a Short Training Period With an APOS (All Phase Of Step Cycle) KitStatus unknownNCT00338637Phase 2
• Gait Evaluation in Multiple Sclerosis Patients Treated With Glatiramer AcetateStatus unknownNCT00331747Not applicable
• Infections and Autoimmunity: Autobodies Screening in Multiple SclerosisStatus unknownNCT00230204Phase 1
• TCV -01-002: T-Cell Vaccination in the Treatment of Probable Multiple SclerosisStatus unknownNCT00228228Phase 3
• Fatigue Treatment Using ProvigilStatus unknownNCT00220506Not applicable
• Evaluation of Efficiency of Ritalin in Multiple Sclerosis (MS) PatientsStatus unknownNCT00220493Phase 1
• T-Cell Vaccination in Multiple Sclerosis (MS)Status unknownNCT00220428Phase 1/2